Document Detail


Heart failure biomarkers: focus on interleukin-1 receptor-like 1-based blood tests.
MedLine Citation:
PMID:  22844659     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
Heart failure is a leading cause of morbidity and mortality in the Western world. It is often a progressive disease, and the pathophysiology behind this adverse development is not completely understood. Biomarkers are of increasing importance in heart failure research. Despite a growing number of candidate markers, only a select few have made it into clinical practice. Interleukin-1 receptor-like 1 (IL1RL1), also known as protein ST2, is the receptor for interleukin-33 (IL-33), a cytokine involved in T-cell-mediated immune responses. IL1RL1 expression is induced by cardiomyocyte stretch, and IL1RL1 may thus reflect the activity of two interacting processes in heart failure: inflammation and hemodynamic stress. In recent years, the soluble, truncated IL1RL1 isoform B has been shown to provide prognostic information in heart failure. Although ILRL1 isoform B does not seem to aid in the diagnosis of the disease, an elevated plasma/serum concentration of this marker is firmly associated with adverse outcome in patients with heart failure. This association has been established in different heart failure cohorts and is independent of age, etiology of heart failure and left ventricular function. Ultimately, the IL-33/IL1RL1 pathway may become a therapeutic target in heart failure.
Authors:
K Broch; T Ueland; A Yndestad; P Aukrust; L Gullestad
Related Documents :
15248449 - Magnetic resonance imaging of acute myocardial ischaemia and infarction.
22121069 - Five-minute heart rate variability can predict obstructive angiographic coronary disease.
21730309 - Development and validation of a risk calculator for prediction of cardiac risk after su...
17440639 - Contrast echocardiography in canada: canadian cardiovascular society/canadian society o...
15312019 - Active distal coronary perfusion to prevent regional myocardial ischemia in off-pump co...
17574429 - Microheterogeneity of regional myocardial blood flows in low-perfused rat hearts evalua...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Drugs of today (Barcelona, Spain : 1998)     Volume:  48     ISSN:  1699-3993     ISO Abbreviation:  Drugs Today     Publication Date:  2012 Jul 
Date Detail:
Created Date:  2012-07-30     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101160518     Medline TA:  Drugs Today (Barc)     Country:  United States    
Other Details:
Languages:  eng     Pagination:  479-91     Citation Subset:  IM    
Copyright Information:
Copyright 2012 Prous Science, S.A.U. or its licensors. All rights reserved.
Affiliation:
Department of Cardiology, Oslo University Hospital, Rikshospitalet, and Faculty of Medicine, University of Oslo, Oslo, Norway. kaspar.broch@ous-hf.no.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Glutamatergic approaches in major depressive disorder: focus on ketamine, memantine and riluzole.
Next Document:  A report from the American Society of Hypertension's 2012 annual scientific meeting and exposition (...